Are you Dr. Randolph Jackson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 53 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
110 Irving St Nw
Washington, DC 20010Phone+1 800-353-0788Fax+1 804-355-6031
Summary
- Dr. Pamela Randolph Jackson, MD is a radiation oncologist in Washington, District of Columbia. She is currently licensed to practice medicine in District of Columbia, Nevada, and California. She is affiliated with MedStar Washington Hospital Center.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 1992 - 1993
Howard UniversityResidency, Radiation Oncology, 1989 - 1992- Howard UniversityInternship, Transitional Year, 1988 - 1989
East Tennessee State University James H. Quillen College of MedicineClass of 1988
Certifications & Licensure
MD State Medical License 1991 - 2025
CA State Medical License 2014 - 2024
DC State Medical License 1991 - 2024
IL State Medical License 1998 - 2023
IN State Medical License 2009 - 2023
NC State Medical License 2013 - 2023
FL State Medical License 2013 - 2022- American Board of Radiology Radiation Oncology
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsAn exercise trial to reduce cancer related fatigue in African American breast cancer patients undergoing radiation therapy: Design, rationale, and methods ☆Chiranjeev Dash, Pamela Randolph-Jackson, Claudine Isaacs, Mary Mills, Kepher H. Makambi
Contemporary Clinical Trials. 2016-03-01 - 50 citationsRisk Factors for Posttreatment Edema in Patients Treated With Stereotactic Radiosurgery for MeningiomasKeith Unger, C.E. Lominska, June Chanyasulkit, Pamela Randolph-Jackson, Robert L. White
Neurosurgery. 2012-03-01 - 18 citationsVideo intervention increases participation of black breast cancer patients in therapeutic trials.Brandi N. Robinson, Antoinette F. Newman, Eshetu Tefera, P. Herbolsheimer, Raquel Nunes
NPJ Breast Cancer. 2017-09-18
